CAS: 73360-54-0; 1-Butyl-N-(2,6-Dimethylphenyl)Piperidine-2-Carboxamide Hydrochloride Hydrate

化学文摘社编号为7360-54, 能够精确地识别和检索有关其合成,特性和在研究和工业中的潜在应用的信息.与许多化学物质一样,在处理和毒性信息时应当参考安全数据表.

结构式图片

欧盟法规

C&L通报

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-2012177593-A1
    优先权日:2009-07-20
    标 题 :Synthesis of dendrimer conjugates
    发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH
    权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.

    专利号:US-2014205671-A1
    优先权日:2013-01-18
    标题 :Synthesis and use of polyhydroxyalkanoate (pha) nanocapsules as a protein carrier
    发明人:YU PETER HOI FU; CHAN ALEX HO YIN; HO KWOK PING
    权利人:NANO & ADVANCED MATERIALS INST LTD
    摘要:A method of synthesizing PHA nanocapsules as a protein carrier, particularly, the synthesis of PHA nanocapsules synthesized by a modified precipitation/solvent evaporation technique with neutralization. Specifically, the method comprises the steps of sonicating a first solution comprising a triblock PHA copolymer, stirring the first solution into a second solution to give a third solution, the second solution containing a protein, and the second solution being acidic. Further, the method comprises adding the third solution with a neutralizing agent to give a neutralized solution, and sonicating the neutralized solution to form a final solution, wherein the synthesized PHA nanocapsules containing the protein are formed in the final solution. Further, PHA nanocapsules encapsulated with the protein is used by administering the synthesized PHA nanocapsule to an animal in need thereof via the oral cavity.

    专利号:US-2023047214-A1
    优先权日:2020-02-03
    标题:Methods for microwave synthesis of degradable polymers for drug delivery
    发明人:MURATOGLU ORHUN K; ORAL EBRU; GRINDY SCOTT
    权利人:MASSACHUSETTS GEN HOSPITAL
    摘要:Provided herein are methods of making degradable, additive-blended polymeric materials using microwave radiation and catalysts. The methods can include incorporation of therapeutic materials into the polymeric materials. There also are provided polymeric materials made by the methods and medical devices comprising the polymeric materials made by the methods.

    专利号:US-12295961-B2
    优先权日:2009-12-31
    标 题:Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols
    发明人:DHINGRA OM
    权利人:MARIUS PHARMACEUTICALS INC
    摘要:A formulation for drug delivery, providing enhanced modulation of solubility, stability, absorption, metabolism, and/or pharmacokinetic profile of a lipophilic therapeutic agent by formulation with sterols and/or sterol esters, resulting in higher bioavailability of a therapeutic agent administered to a subject in need of such therapeutic agent. The formulation contains a therapeutic agent and a sterol or sterol ester, and can, optionally, further contain a solubilizer and/or an enhancing agent. Also described are pharmaceutical compositions containing the formulations and methods of making and methods of using the formulations and pharmaceutical compositions. Formulations of the disclosure can be constituted to minimize the synthesis of dihydrotestosterone when the therapeutic agent includes testosterone or testosterone esters.

    专利号:WO-9628426-A1
    优先权日:1995-03-10
    标 题 :N-alkylpipecolic acid compounds, their preparation and use in the synthesis of levobupivacaine and analogues
    发明人:DYER ULRICH CONRAD; ZAVAREH HOOSHANG SHAHRIARI
    权利人:CHIROSCIENCE LTD; DYER ULRICH CONRAD; ZAVAREH HOOSHANG SHAHRIARI
    摘要:Optically-enriched N,O-dialkyl pipecolates are useful in the preparation of levobupivacaine and related analgesics. They may be prepared simply by dialkylating optically-enriched pipecolic acid by reaction with an alkylating agent, in the presence of base and a polar aprotic solvent.

    专利号:US-9650407-B2
    优先权日:2011-11-02
    标 题 :Reprogramming of cellular adhesion
    发明人:GARTNER ZEV JORDAN; SELDEN NICHOLAS SCOTT; TODHUNTER MICHAEL E; LIANG SAMANTHA ISABEL; WEBER ROBERT JOSEPH; JEE NOEL YOUNGHO; LIU JENNIFER S
    权利人:UNIV CALIFORNIA
    摘要:Disclosed are membrane-anchored polynucleotides, and compositions comprising the membrane-anchored polynucleotides. Also disclosed are the processes for the synthesis of these compounds, compositions comprising such compounds, and the use of such compounds and compositions in research and therapeutic applications.
    山东诚汇医药集团有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jnchsd.com
    企业联系电话:0531-58897025-13589078718👤
    📞山东诚汇医药集团有限公司 ⚠️参考联系方式
    联系人:刘吉华
    电话:0531-58897025-13589078718
    手机:13589078718

    邮箱:market@jnchsd.com
    通信地址: 济南市高新技术开发区开拓路2350号
    邮编: 250101
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:济南市高新技术开发区开拓路2350号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Prabhakar A, Ward CT, Watson M, Sanford J, Fiza B, Moll V, Kaye RJ, Morgan Hall O, Cornett EM, Urman RD, Kaye AD. Liposomal bupivacaine and novel local anesthetic formulations. Best Pract Res Clin Anaesthesiol. 2019 Dec;33(4):425-432. doi: 10.1016/j.bpa.2019.07.012. Epub 2019 Jul 19. 68(7):365-369. doi: 10.1055/s-0043-121142. Epub 2017 Nov 6. 138(4):748e-756e. doi: 10.1097/PRS.0000000000002547. 2021 Jan–. 19(2):247-68. doi: 10.1016/j.bpa.2004.12.003. 31(5):636-642. doi: 10.1097/ACO.0000000000000648. 2(2):CD011419. doi: 10.1002/14651858.CD011419.pub2.
    8: Malik O, Kaye AD, Kaye A, Belani K, Urman RD. Emerging roles of liposomal bupivacaine in anesthesia practice. J Anaesthesiol Clin Pharmacol. 2017 Apr- Jun;33(2):151-156. doi: 10.4103/joacp.JOACP_375_15.
    9: Uppal V, Retter S, Shanthanna H, Prabhakar C, McKeen DM. Hyperbaric Versus Isobaric Bupivacaine for Spinal Anesthesia: Systematic Review and Meta-analysis for Adult Patients Undergoing Noncesarean Delivery Surgery. Anesth Analg. 2017 Nov;125(5):1627-1637. doi: 10.1213/ANE.0000000000002254. 2006–. Bupivacaine. 2020 Nov 16. 45(1):68-73. doi: 10.1097/DSS.0000000000001628. 28(1):15-27. doi: 10.1016/j.bpa.2014.02.001. Epub 2014 Mar 15. 28(5):593-7. doi: 10.1097/ACO.0000000000000240. 44(3):111-7. 134(2):283-344. doi: 10.1097/ALN.0000000000003630. 96(25):e7190. doi: 10.1097/MD.0000000000007190.

    合成参考文献


    参考文献:10.1007/s00101-011-1913-0
    摘要:Geze S, Imamoğlu M, Cekic B. Awake caudal anesthesia for inguinal hernia operations: successful use in low birth weight neonates. Anaesthesist. 2011 Sep;60(9):841–4. doi: 10.1007/s00101-011-1913-0.
    参考文献:10.1186/2046-0481-64-3
    摘要:Huuskonen V, Hughes L, Bennett R. Anaesthesia of three young grey seals (Halichoerus grypus) for fracture repair. Irish Veterinary Journal. 2011 Mar 31;64(1):3. doi: 10.1186/2046-0481-64-3.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知